Effects of Compound Zhebei Granule (复方浙贝颗粒) Combined with Doxorubicin on Expression of Specific Surface Antigens in Mice with Transplanted KG-1a Cells

Yu Zhang; li Hou; Xin-yi Chen

doi:10.1007/s11655-017-2963-1

Your Location：

Home >

Browse articles >

Effects of Compound Zhebei Granule (复方浙贝颗粒) Combined with Doxorubicin on Expression of Specific Surface Antigens in Mice with Transplanted KG-1a Cells

OriginalPaper | Updated：2021-08-27

- Effects of Compound Zhebei Granule (复方浙贝颗粒) Combined with Doxorubicin on Expression of Specific Surface Antigens in Mice with Transplanted KG-1a Cells
- Effects of Compound Zhebei Granule (复方浙贝颗粒) Combined with Doxorubicin on Expression of Specific Surface Antigens in Mice with Transplanted KG-1a Cells
- 中国结合医学杂志（英文版） 2018年24卷第3期页码：213-217
- Affiliations：
  
  1. Department of Integrated Chinese and Western Medicine, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer Tianjing, Tianjing,China
  2. Key Laboratory of Cancer Prevention and Therapy,Tianjin,China
  3. Tianjin Clinical Research Center for Cancer,Tianjin,China
  4. Department of Hematology, Dongzhimen Hospital Affiliated to Beijing University of Chinese Medicine,Beijing,China
- Author bio：
- Funds：
- DOI：10.1007/s11655-017-2963-1
  中图分类号：
- 纸质出版日期：2018，
  
  网络出版日期：2017-10-6，
Scan for full text
Zhang, Y., Hou, l. & Chen, Xy. Effects of Compound Zhebei Granule (复方浙贝颗粒) Combined with Doxorubicin on Expression of Specific Surface Antigens in Mice with Transplanted KG-1a Cells., Chin. J. Integr. Med. 24, 213–217 (2018). https://doi.org/10.1007/s11655-017-2963-1

Yu Zhang, li Hou, Xin-yi Chen. Effects of Compound Zhebei Granule (复方浙贝颗粒) Combined with Doxorubicin on Expression of Specific Surface Antigens in Mice with Transplanted KG-1a Cells[J]. Chinese Journal of Integrative Medicine, 2018,24(3):213-217.
Zhang, Y., Hou, l. & Chen, Xy. Effects of Compound Zhebei Granule (复方浙贝颗粒) Combined with Doxorubicin on Expression of Specific Surface Antigens in Mice with Transplanted KG-1a Cells., Chin. J. Integr. Med. 24, 213–217 (2018). https://doi.org/10.1007/s11655-017-2963-1 DOI：

Yu Zhang, li Hou, Xin-yi Chen. Effects of Compound Zhebei Granule (复方浙贝颗粒) Combined with Doxorubicin on Expression of Specific Surface Antigens in Mice with Transplanted KG-1a Cells[J]. Chinese Journal of Integrative Medicine, 2018,24(3):213-217. DOI： 10.1007/s11655-017-2963-1.

摘要

To investigate the effects of Compound Zhebei Granule (复方浙贝颗粒

CZG) combined with doxorubicin hydrochloride (adriamycin

ADM) on specific surface antigens in mice with KG-1a transplanted cells. A subcutaneous tumor xenograft model was established by injection of the acute myeloid leukemia cell line KG-1a into the axillary flfl anks of BALB/c-nude mice. Twenty-four tumor bearing mice were divided into 4 groups according to a random number table

including normal saline control group

ADM group

high-dose CZG group

and mid-dose CZG group

with 6 mice in each group. Drug administration occurred on the 14th day after cell inoculation

and normal saline control group mice were gavaged with normal saline at 0.2 mL/10 g every other day. ADM group mice were intraperitoneally injected with ADM 1 mg/kg [conversion of adults

40 mg/(m2•d)] every other day. High- and mid-dose CZG groups mice were gavaged with CZG at the dose of 8 and 4 g/kg respectively every other day and intraperitoneally injected with ADM (1 mg/kg) every other day. The administration period lasted for 10 days. The tumor xenografts were made into mononuclear cell suspensions after dissection

and the expressions of specific surface antigens

including CD34+CD38-

CD34+CD38-CD123+

CD34+CD38-CD96+ and CD34+CD38-CD33+

in KG-1a cell line tumor xenografts were detected by flfl ow cytometry. Compared with the control and ADM groups

expression of CD34+CD38- in the two CZG groups was significantly lower (P<0.05). Compared with the control group

expression of CD34+CD38-CD123+ in the two CZG groups decreased (P<0.05). The high-dose CZG group showed more obvious outcomes compared with the ADM group (P<0.05). Compared with the control and ADM groups

the expression of CD34+CD38-CD96+ and CD34+CD38-CD33+ in the two CZG groups decreased (P<0.05). CZG combined with doxorubicin could reduce the expression of CD34+CD38-

CD34+CD38-CD123+

CD34+CD38-CD96+ and CD34+CD38-CD33+ in KG-1a cell line tumor xenografts

which shows that CZG could target leukemia stem cells and play a role in chemosensitization.

Abstract

To investigate the effects of Compound Zhebei Granule (复方浙贝颗粒

CZG) combined with doxorubicin hydrochloride (adriamycin

including normal saline control group

ADM group

high-dose CZG group

and mid-dose CZG group

with 6 mice in each group. Drug administration occurred on the 14th day after cell inoculation

and normal saline control group mice were gavaged with normal saline at 0.2 mL/10 g every other day. ADM group mice were intraperitoneally injected with ADM 1 mg/kg [conversion of adults

and the expressions of specific surface antigens

including CD34+CD38-

CD34+CD38-CD123+

CD34+CD38-CD96+ and CD34+CD38-CD33+

in KG-1a cell line tumor xenografts were detected by flfl ow cytometry. Compared with the control and ADM groups

expression of CD34+CD38- in the two CZG groups was significantly lower (P<0.05). Compared with the control group

the expression of CD34+CD38-CD96+ and CD34+CD38-CD33+ in the two CZG groups decreased (P<0.05). CZG combined with doxorubicin could reduce the expression of CD34+CD38-

CD34+CD38-CD123+

CD34+CD38-CD96+ and CD34+CD38-CD33+ in KG-1a cell line tumor xenografts

which shows that CZG could target leukemia stem cells and play a role in chemosensitization.

关键词

acute myeloid leukemiaChinese Medicinedoxorubicinadriamycin

Keywords

acute myeloid leukemiaChinese Medicinedoxorubicinadriamycin

references

Wang Y, Han HX, Zhang JC, Zhu P. Resistance mechanisms and targeted therapy in leukemia stem cells. J Mod Oncol (Chin) 2011;19:1457–1460.

Li DY, TIan SD, Ye PZ, Zhang Y, Chen XY. Study of Compound Zhe Bei Particles improve clinical curative effect of the acute refractory leukemia adjuvant chemotherapy. Beijing J Tradit Chin Med (Chin) 2007;26:72–74.

Chen XY, Li DY, Tian SD. Diagnosis and treatment of refractory acute leukemia. J Chin Integr Med (Chin) 2009;29:177–182.

Song B, Zhang RY. Expression and its clinical sense of CDl23 on bone marrow stem cells and progenitor cells of patients with acute leukemia. Jiangxi Med J (Chin) 2010;45:305–306.

Han YL, Liu X, Li QW. Advances in signal transduction and functional of CD33 molecular. J Shangqiu Norm Univ (Chin) 2010;26(3):1–5.

Fuchs A, Cella M, Giurisato E, Shaw AS, Colonna M. Cutting edge: CD96 (tactile) promotes NK cell-target cell adhesion by interacting with thepoliovirus receptor (CD155). J Immunol 2004;172:3994–3998.

Gramatzki M, Ludwig WD, Burger R, Moos P, Rohwer P, Grünert C, et al. Antibodies TC-12 ("unique") and TH-111 (CD96) characterize T cell acute lymphoblastic leukemia and a subgroup of acute myeloid leukemia. Exp Hematol 1998;126:1209–1214.

Hosen N, Park CY, Tatsumi N, Oji Y, Sugiyama H. CD96 is a leukemia stem cell specific marker in human acute myeloid leukemia. Proc Natl Acad Sci USA 2007;104:11008–11013.

Wu Y, Xiao M, Zhu L, Zhou XX, Long Q, Xin X, et al. CD96 expression on bone marrow mononuclear cells in 91 patients with acute leukemia. J Exp Hematol (Chin) 2011;19:585–588.

She MR, Niu XQ, Chen XL, Li JG, Zhou MH, He YJ, et al. Resistance of leukemic stem-like cells in AML cell line KG-1a to natural killer. Cancer Let 2012;318:173–179.

FULL TEXT LINK

More>

浏览量

Downloads

CSCD

文章被引用时，请邮件提醒。

Submit

工具集

关联资源

Integrative oncology meets immunotherapy: New prospects for combination therapy grounded in Eastern medical knowledge

Future view and development of immunology: Exploring the immunology based on Chinese medicine and culture

Cost-effectiveness analysis of combined Chinese medicine and Western medicine for ischemic stroke patients

Objective tongue inspection on 142 liver cancer patients with damp-heat syndrome

Effect of Ermiao Recipe (二妙方) with medicinal guide Angelicae Pubescentis Radix on promoting the homing of bone marrow stem cells to treat cartilage damage in osteoarthritis rats